IMR Press / FBS / Volume 12 / Issue 1 / DOI: 10.2741/S539

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review
Anti-atherosclerotic and cardiovascular protective benefits of Brazilian nuts
Show Less
1 Instituto de Ciencias Biologicas e da Saude, Campus Universitario do Araguaia, Universidade Federal de Mato Grosso, Av. Valdon Varjao, 6390, Setor Industrial, Barra do Garcas, 78.600-000, MT, Brazil
Send correspondence to: Carlos K B Ferrari, ICBS, Campus do Araguaia, Universidade Federal de Mato Grosso (UFMT), Av. Valdon Varjao, 6390, Setor Industrial, Barra do Garças, 78. 600-000, MT, Brazil, Tel: 55663402-0717, Fax: 55663402-0718, E-mail: drcarlosferrari.ufmt@gmail.com
Front. Biosci. (Schol Ed) 2020, 12(1), 38–56; https://doi.org/10.2741/S539
Published: 1 January 2020
(This article belongs to the Special Issue New trends in atherosclerosis research)
Abstract

Brazil nuts are rich in magnesium, selenium, arginine and other amino acids, dietary fiber, tocopherols (vitamin E), phytosterols, linoleic acid, linolenic acid, sitosterols, monounsaturated and polyunsaturated fatty acids, polyphenols and other amino acids. Due to such a rich mixture of nutrients, Brazil nuts protect LDL from peroxidation, and improve endothelial function, blood pressure, lipid metabolism, and decrease endothelial inflammatory markers, DNA oxidation, and blood lipids (cholesterol, LDL, triglycerides). Here, we review and propose biological mechanisms by which bioactive compounds of Brazil nuts afford protections against atherosclerosis and cardiovascular diseases. Just a few nuts per day provide sufficient cardiovascular benefits, including protection against development and progression of atherosclerosis.

Keywords
Atherosclerosis
beta-sitosterol
Linolenic acid
Magnesium
Tocopherol
Selenium
Arginine
Review
Figures
Figure 1
Share
Back to top